Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
795.4000 -25.35 (-3.09%)
NSE Sep 29, 2025 15:31 PM
Volume: 727.8K
 

logo
Natco Pharma Ltd.
24 May 2018
795.40
-3.09%
ICICI Securities Limited
EBITDA margins improved 723 bps YoY to 50% (I-direct estimate: 57.6%) mainly due to better realisation from limited competition launches in the US. However, it was below I-direct estimates mainly due to lower gross margins (84% vs. I-direct estimate of 90%) Adjusted net profit increased 69.7% YoY to | 300 crore (I-direct...
Natco Pharma Ltd. has an average target of 1294.50 from 4 brokers.
More from Natco Pharma Ltd.
Recommended